# PANIXINE DISPERDOSE
> **ANDA065100** · Abbreviated New Drug Application (Generic) · Sponsor: RANBAXY LABS LTD · Approved 2003-09-11
## Drug
- **FDA Application Number:** ANDA065100
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PANIXINE DISPERDOSE
- **Generic name:** Cephalexin
- **Active ingredients:** CEPHALEXIN
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** RANBAXY LABS LTD
- **First approval:** 2003-09-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065100)
---
*MORVS · CC0 1.0*